Vivek Balasubramanian: Where Financial Discipline Meets Healthcare Innovation
Vivek Balasubramanian
Chief Financial Officer
In this environment, Chief Financial Officers have emerged as key business partners, helping organizations navigate complex financial landscapes while enabling innovation that delivers meaningful impact across the healthcare ecosystem.
Vivek Balasubramanian, Chief Financial Officer of Fischer Medical Ventures is one such leader who brings a strategic and collaborative approach to financial leadership.
A Chartered Accountant by profession, Vivek considers qualifying as a Chartered Accountant to be a key milestone of his career.
Achieving this long-held goal instilled in him the values of discipline, resilience, and continuous learning - principles that continue to shape his leadership philo- sophy.
Although he has received numerous professional recognitions throughout his career, this accomplishment remains the one he values most.
Before joining Fischer Medical Ventures, Vivek built a strong foundation in finance and business management through his experience with leading global professional services firms, including EY, KPMG and PwC.
These experiences broadened his perspective beyond traditional finance functions, reinforcing his belief that a modern CFO must understand the business holistically collaborate across departments, and actively contribute to strategic decision-making.
As CFO of Fischer Medical Ventures, Vivek champions the idea that finance should serve as a business enabler rather than merely a control function. His leadership is rooted in collaboration, transparency, and disciplined financial manage- ment, while embracing technology and data-driven decision-making to support sustainable organizational growth.
By aligning financial strategy with business objectives, he continues to strengthen Fischer Medical Ventures' position in the rapidly evolving health technology landscape, ensuring that financial excellence goes hand in hand with innovation and long-term value creation. Let’s read on.
Finance leaders today play a much broader strategic role than traditional reporting and compliance. How do you ensure financial strategy remains aligned with overall business objectives?
I believe finance delivers the greatest value when it operates as a strategic partner rather than a support function that validates decisions after execution.
At Fischer Medical Ventures, we align financial planning with the organization's strategic priorities from the outset.
While regulatory compliance and reporting are non-negotiable for a listed company, I see them as tools that strengthen decision-making rather than restrict growth.
I also work to change how finance is perceived - moving it beyond a control function to one that provides real-time insights, enables collaboration, and empowers every business team to achieve shared organizational goals.
In healthcare, where innovation directly impacts patient outcomes how do you evaluate investments that balance commercial success with long-term strategic value?
Healthcare investments require a broader perspective because their impact extends beyond financial returns to patient lives and organizational credibility.
I begin with thorough commercial and financial due diligence, evaluating revenue models, growth potential, and operational sustain ability.
Beyond that I assess whether an investment strengthens our portfolio, complements Fischer Medical Ventures' long-term strategy, creates meaningful synergies, and positions us for emerging healthcare trends. Scalability is equally important.
I believe the best investments are those that combine commercial viability, strategic resilience, and the ability to create lasting value for both the organization and the healthcare ecosystem.
Transparency and account ability are increasingly important to stakeholders. How do you build lasting trust with investors, partners, and internal teams?
Trust is built through consistency, transparency, and accountability. Whether communicating with investors or business partners, I discuss both successes and challenges honestly because stakeholders value credibility more than perfection.
Internally, we focus on positioning finance as a collaborative partner rather than a gatekeeper.
I believe finance delivers the greatest value when it operates as a strategic partner rather than a support function that validates decisions after execution.
At Fischer Medical Ventures, we align financial planning with the organization's strategic priorities from the outset.
I value curiosity, adapt ability, resilience, and people who embrace change, understand the business, and actively improve performance together
While regulatory compliance and reporting are non-negotiable for a listed company, I see them as tools that strengthen decision-making rather than restrict growth.
I also work to change how finance is perceived - moving it beyond a control function to one that provides real-time insights, enables collaboration, and empowers every business team to achieve shared organizational goals.
In healthcare, where innovation directly impacts patient outcomes how do you evaluate investments that balance commercial success with long-term strategic value?
Healthcare investments require a broader perspective because their impact extends beyond financial returns to patient lives and organizational credibility.
I begin with thorough commercial and financial due diligence, evaluating revenue models, growth potential, and operational sustain ability.
Beyond that I assess whether an investment strengthens our portfolio, complements Fischer Medical Ventures' long-term strategy, creates meaningful synergies, and positions us for emerging healthcare trends. Scalability is equally important.
I believe the best investments are those that combine commercial viability, strategic resilience, and the ability to create lasting value for both the organization and the healthcare ecosystem.
Transparency and account ability are increasingly important to stakeholders. How do you build lasting trust with investors, partners, and internal teams?
Trust is built through consistency, transparency, and accountability. Whether communicating with investors or business partners, I discuss both successes and challenges honestly because stakeholders value credibility more than perfection.
Internally, we focus on positioning finance as a collaborative partner rather than a gatekeeper.
By understanding business priorities, supporting operational teams, and working towards common objectives, finance becomes an enabler of growth instead of a constraint. Over time, this collaborative approach creates stronger relationships, greater confidence, and a culture built on mutual trust and shared success.
What qualities do you believe are essential for building a high-performing finance team that can support long-term organi- zational growth?
Capability matters far more than age or generational labels. What I value most are curiosity, adaptability, resilience, and a willingness to embrace change. I look for people who want to understand the business beyond their immediate responsibilities and actively contribute to improving performance.
Collaboration is equally important because the best finance teams don't simply report numbers - they help shape business outcomes. By fostering an environment where diverse ideas are welcomed and continuous learning is encouraged, finance teams can become true drivers of sustainable organizational growth.
How do you see the role of the CFO evolving over the next decade, and what advice would you offer aspiring finance leaders?
The CFO's role is evolving from financial stewardship to strategic business leader - ship. Today's finance leaders must be equally comfortable discussing commercial strategy operations, technology, people, and transformation - not just financial reporting.
The CFO of the future will play an increasingly important role in shaping business direction while maintaining strong governance and financial disci -pline. For any aspiring finance leader — go beyond the numbers. The numbers matter, but they're not the ceiling.
Develop a deep understanding of the business embrace technology stay adaptable, and continuously broaden your perspective because future CFOs will help create value, not simply measure it.
Vivek Balasubramanian, Chief Financial Officer, Fischer Medical Ventures
Vivek Balasubramanian is the Chief Financial Officer of Fischer Medical Ventures, bringing extensive experience in finance, business management, and strategic leadership.
A Chartered Accountant by profession, he has previously worked with leading global firms including EY and PwC before joining Fischer Medical Ventures. He is passionate about leveraging finance as a strategic business partner, driving sustainable growth through collaboration, technology, and disciplined financial manage- ment.
What qualities do you believe are essential for building a high-performing finance team that can support long-term organi- zational growth?
Capability matters far more than age or generational labels. What I value most are curiosity, adaptability, resilience, and a willingness to embrace change. I look for people who want to understand the business beyond their immediate responsibilities and actively contribute to improving performance.
Collaboration is equally important because the best finance teams don't simply report numbers - they help shape business outcomes. By fostering an environment where diverse ideas are welcomed and continuous learning is encouraged, finance teams can become true drivers of sustainable organizational growth.
How do you see the role of the CFO evolving over the next decade, and what advice would you offer aspiring finance leaders?
The CFO's role is evolving from financial stewardship to strategic business leader - ship. Today's finance leaders must be equally comfortable discussing commercial strategy operations, technology, people, and transformation - not just financial reporting.
The CFO of the future will play an increasingly important role in shaping business direction while maintaining strong governance and financial disci -pline. For any aspiring finance leader — go beyond the numbers. The numbers matter, but they're not the ceiling.
Develop a deep understanding of the business embrace technology stay adaptable, and continuously broaden your perspective because future CFOs will help create value, not simply measure it.
Vivek Balasubramanian, Chief Financial Officer, Fischer Medical Ventures
Vivek Balasubramanian is the Chief Financial Officer of Fischer Medical Ventures, bringing extensive experience in finance, business management, and strategic leadership.
A Chartered Accountant by profession, he has previously worked with leading global firms including EY and PwC before joining Fischer Medical Ventures. He is passionate about leveraging finance as a strategic business partner, driving sustainable growth through collaboration, technology, and disciplined financial manage- ment.